Crustacean Cardioactive Peptide (CCAP);(Synonyms: 甲壳类心脏活性肽) 纯度: 99.66%
Crustacean Cardioactive Peptide (CCAP) 是一个高度保守的九肽,最早是从普通滨蟹的围心器官中分离到的,具有调节心跳的作用;Crustacean Cardioactive Peptide (CCAP) 同时在其他节肢动物中,能够调节神经活动。
Crustacean Cardioactive Peptide (CCAP) Chemical Structure
CAS No. : 309247-84-5
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
1 mg | ¥800 | In-stock | |
5 mg | ¥3200 | In-stock | |
10 mg | ¥5600 | In-stock | |
50 mg | ; | 询价 | ; |
100 mg | ; | 询价 | ; |
* Please select Quantity before adding items.
Crustacean Cardioactive Peptide (CCAP) 相关产品
bull;相关化合物库:
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Peptide Library
生物活性 |
Crustacean Cardioactive Peptide (CCAP) is a highly conserved, amidated cyclic nonapeptide, first isolated from the pericardial organs of the shore crab Carcinus maenas, where it has a role in regulating heartbeat; Crustacean Cardioactive Peptide (CCAP) also modulates the neuronal activity in other arthropods. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Ultrabithorax and Abdominal-A are not necessary for specification of the CCAP-interneurons, but are absolutely required to prevent the death by apoptosis of the CCAP-efferent neurons[2]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
体内研究 (In Vivo) |
CCAP, FMRFamide and SALDKNFMRFamide increase the mosquito antennal accessory pulsatile organ (APO) and heart contraction rates, increase hemolymph flow velocity in the antennal space[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
959.10 |
||||||||||||||||
Formula |
C42H58N10O12S2 |
||||||||||||||||
CAS 号 |
309247-84-5 |
||||||||||||||||
Sequence |
Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys |
||||||||||||||||
Sequence Shortening |
PFCNAFTGC |
||||||||||||||||
中文名称 |
甲壳类心脏活性肽 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:;
DMSO : 50 mg/mL (52.13 mM; Need ultrasonic) H2O : 0.67 mg/mL (0.70 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|